Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

摘要

The 5-year disease-specific survival probability of pseudomyxoma peritonei patients after treatment by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy reaches 60%. Patients with pseudomyxoma peritonei pathologically categorized as adenomucinosis benefit most from this treatment strategy with a 5-year disease-specific survival probability of 72%.